EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Characterization and management of patients with hereditary factor X deficiency: A case series

Meera Chitlur iD, Lauren E Amos iD, Mark T Reding iD, Cynthia Sabo iD, Suchitra S Acharya iD

Transfusion · 2025-10 · 65 (10) · 1786-1792

DOI: 10.1111/trf.18377 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Transfusion, online erschienen am 11.08.2025. Verfasst von Meera Chitlur und 4 weiteren Autor:innen. Beteiligte Einrichtung: Central Michigan University School of Medicine, Children's Hospital of Michigan, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: Factor X Deficiency. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Kedrion Biopharma, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hereditary factor X deficiency (HFXD) is an ultra‐rare, autosomal recessive bleeding disorder that results in reduced factor X coagulant activity (FX:C). HFXD is traditionally classified by severity as severe (FX:C 5%, with 2 and 12 patients classified as EN‐RBD mild and moderate, respectively. Twenty patients experienced bleeding episodes requiring treatment. Bleeding episodes were heterogeneous, ranging from epistaxis to spontaneous subdural hematoma; treatments included antifibrinolytics, hormonal therapy, and factor replacement. Seven patients with FX:C >40% had bleeding episodes that required treatment, and 3 of them experienced multiple bleeding episodes.

Discussion

HFXD presents with variable bleeding phenotypes that may not correlate with FX:C levels. This analysis demonstrates that while bleeding phenotypes generally align with the revised EN‐RBD classification, patients with mild or moderate HFXD can experience significant bleeding. Future work should focus on correlating genotype with phenotype and refining management guidelines for mild and moderate HFXD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Factor X DeficiencyHumansMaleFemaleRetrospective StudiesAdultAdolescentMiddle AgedChildHemorrhageYoung AdultChild, PreschoolAged

Stichwörter der Autor:innen

hemostasis

Autor:innen und Institutionen

  • Central Michigan University School of Medicine, Children's Hospital of Michigan, Detroit, Michigan, USA.
  • Division of Hematology/Oncology, Children's Hospital of Michigan, Detroit, Michigan, USA.
  • Division of Hematology/Oncology, Children's Mercy Hospital, Kansas City, Missouri, USA.
  • Center for Bleeding and Clotting Disorders, University of Minnesota Medical Center, Minneapolis, Minnesota, USA.
  • Northwell and Cohen Children's Medical Center Northwell, New Hyde Park, New York, USA.

ORCID-Profile: Meera Chitlur, Lauren E Amos, Mark T Reding, Cynthia Sabo, Suchitra S Acharya

Förderung

  • Kedrion Biopharma, Inc.

Zitieren

APA

Chitlur, M., Amos, L. E., Reding, M. T., Sabo, C., & Acharya, S. S. (2025). Characterization and management of patients with hereditary factor X deficiency: A case series. Transfusion, 65(10), 1786-1792. https://doi.org/10.1111/trf.18377

Vancouver

Chitlur M, Amos LE, Reding MT, Sabo C, Acharya SS. Characterization and management of patients with hereditary factor X deficiency: A case series. Transfusion. 2025;65(10):1786-1792. doi:10.1111/trf.18377

BibTeX
@article{Chitlur2025,
  author = {Chitlur, Meera and Amos, Lauren E and Reding, Mark T and Sabo, Cynthia and Acharya, Suchitra S},
  title = {Characterization and management of patients with hereditary factor X deficiency: A case series},
  journal = {Transfusion},
  year = {2025},
  volume = {65},
  number = {10},
  pages = {1786--1792},
  doi = {10.1111/trf.18377}
}
Kostenlos starten →